May 2025 in “The Journal of Rheumatology” This study reports that even minimal improvements in SLE-related fatigue and skin symptoms are meaningful to patients, supporting the content validity of the FACIT-Fatigue scale for measuring these effects.
May 2025 in “CPT Pharmacometrics & Systems Pharmacology” This study examined the safety profile of ritlecitinib, a drug for alopecia areata, and found that it does not cause significant QTc prolongation or severe lymphopenia, with no unique safety risks expected in adolescents.
April 2025 in “International Journal of Ayurveda and Pharma Research” This case study described the use of Ayurvedic treatments, including internal medications and external applications, which resulted in black hair growth, increased hair density, and reduced hair fall in a 28-year-old woman with premature graying.
April 2025 in “European Psychiatry” This systematic review and meta-analysis found that mood stabilizers used for bipolar disorder, such as lithium, valproate, carbamazepine, and lamotrigine, resulted in varying prevalence of dermatologic side effects, with lamotrigine showing the highest rash incidence, while severe reactions were rare.
March 2025 in “International Journal of Trichology” This case study reported that a 15-year-old female developed acquired localized trichorrhexis nodosa, a hair shaft disorder, due to vigorous rubbing of an herbal powder on her scalp as part of local cultural practices.
April 2024 in “JMIR infodemiology” This study found that TikTok provides valuable insights into experiences with lupus erythematosus, highlighting distress from symptoms, negative perceptions of pharmacologic treatments, and issues with feeling "medically gaslighted.
This report details a case of hair, nail, and pigmentary disorders occurring 10 months after starting abemaciclib for metastatic breast cancer, highlighting that cutaneous side effects, although less frequent, can lead to discontinuation in 25% of cases.
February 2024 in “Journal of ayurveda and integrated medical sciences” This case study suggests that Ayurvedic treatment, including Karanj oil, herbal churna, and leech therapy, provided significant hair regrowth in a 16-year-old with alopecia areata after three months, despite previous unsuccessful conventional medicine treatments.
January 2024 in “International journal of Indian medicine” In this article, the authors aimed to educate readers on common hair disorders linked to improper care, emphasizing prevention and treatment using Ayurvedic principles such as Dincharya and yoga.
November 2023 in “Curēus” This study in Saudi Arabia found that psychological stress was strongly linked to skin symptoms, with conditions like psoriasis, eczema, acne, rash, and baldness showing significant associations, highlighting the importance of considering stress levels when diagnosing skin issues.
October 2023 in “Journal of Indian System of Medicine” This study discusses how Ayurveda approaches the management of premature hair greying differently than contemporary science, emphasizing lifestyle regimens, rejuvenation practices, and the use of herbal drugs rooted in Ayurveda pharmacodynamics.
This study used TikTok videos to explore experiences of individuals with lupus erythematosus, revealing that mucocutaneous symptoms significantly impact mental health and body image, while pharmacologic treatments are often viewed negatively, leading to important implications for clinical interactions and validation.
June 2023 in “British Journal of Dermatology” This study observed that baricitinib treatment led to significant improvements in hair regrowth and quality of life scores in adults with severe alopecia areata over 24 weeks, with an acceptable safety profile as most adverse effects were transient.
January 2023 in “International Journal of Indian Medicine” This review discusses Ayurvedic approaches to treating hair loss, known as Khalitya, but provides no new clinical findings, urging further exploration of traditional methods.
March 2022 in “Journal of clinical case studies reviews & reports” COVID-19 can cause different skin issues, including rashes and hair loss.
January 2022 in “International journal of Ayurveda and pharma research” This review discusses the Ayurvedic perspective on premature graying of hair (Akala Palitam) and reports no new clinical results, emphasizing the need for understanding its etio-pathogenesis for effective management.
December 2021 in “International Journal of Science and Research (IJSR)” This study explored Ayurvedic treatments for Khalitya (Alopecia areata) and found that using Virechana Karma, along with systemic medicines and Rasayan drugs, may be extremely beneficial in managing this condition.
November 2021 in “Egyptian Journal of Medical Microbiology” This study found that protective measures against COVID-19, such as prolonged mask-wearing and frequent hand washing, were associated with skin issues, hair loss, and nail brittleness among participants in Iraq.
October 2021 in “Brazilian Journal of Health Review” This review discusses common dermatological findings related to SARS-CoV-2 infection, noting their variability and potential psychological impact, but reports no new clinical results; further studies are needed for precise characterization.
August 2021 in “Journal of the American Academy of Dermatology” In this study, both physician and patient reports revealed that more severe alopecia areata was associated with higher emotional symptoms and greater activity limitations among patients.
August 2021 in “Journal of skin and stem cell” Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.
February 2020 in “Scholars international journal of traditional and complementary medicine” This article explores Ayurvedic approaches to treating hair disorders and provides no new clinical results, highlighting practices like using herbal treatments for hair loss and greying.
August 2019 in “Reactions Weekly” Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.
October 2018 in “Annals of oncology” This study reported that topical BPM31543 was safe and well-tolerated for patients on taxane-based chemotherapy, with some efficacy indicated in reducing hair loss at all dosages tested.
August 2018 in “International Journal of Research in Dermatology” In this study, cutaneous features like hair loss, malar rash, and photosensitivity were identified as key indicators of disease activity in systemic lupus erythematosus.
April 2018 in “Rheumatology” This study found that self-reported alopecia was common in lupus patients, often characterized by changes in hair texture and volume, and was associated with anti-Ro antibodies and significant anxiety.
October 2017 in “Planta medica international open” This review documents traditional Turkish herbal remedies for skin disorders, noting the diverse use of plant parts but reports no new clinical results; it emphasizes enhancing education on their conscious use.
This study found that the age of onset in systemic lupus erythematosus patients affects clinical features, with juvenile-onset SLE showing more severe disease activity and systemic involvement than adult or late-onset SLE.
June 2016 in “Annals of the Rheumatic Diseases” This study identified early SLE symptoms reported by German patients, suggesting that patient-reported information can enhance the development of classification criteria for early diagnosis.
January 2016 in “Dermatology Review” This review details various skin manifestations linked to different endocrine disorders but does not report any new clinical results.